Healthpeak Properties, Inc. $DOC Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 5.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 662,019 shares of the real estate investment trust’s stock after selling 40,882 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.10% of Healthpeak Properties worth $14,167,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Healthpeak Properties during the 4th quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Healthpeak Properties by 60.3% in the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after purchasing an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in Healthpeak Properties by 214.0% during the second quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust’s stock worth $98,050,000 after buying an additional 2,883,382 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Down 1.2%

DOC stock opened at $20.96 on Friday. The company’s 50 day simple moving average is $21.54 and its 200-day simple moving average is $19.18. The firm has a market capitalization of $14.45 billion, a PE ratio of 59.89, a P/E/G ratio of 2.32 and a beta of 1.01. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. During the same period last year, the company posted $0.46 EPS. The company’s revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.8%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

Analyst Ratings Changes

Several research analysts have weighed in on DOC shares. JPMorgan Chase & Co. upped their target price on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Royal Bank Of Canada lifted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Wells Fargo & Company boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 15th. Raymond James Financial began coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating on the stock. Finally, UBS Group raised their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $21.66.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.